The CEPI Board and Investors Council met in New Delhi, a decade after its last governance meeting in India; DBT and CEPI co-hosted a reception on 13 September 2026.
India accounts for nearly 60% of global vaccine production, supplies over 100 countries and meets more than 65% of WHO's routine immunisation needs.
The Ind-CEPI Mission, run by BIRAC and BRIC-THSTI, produced GEMCOVAC-19, India's first mRNA COVID-19 vaccine.
GS Paper 3 > Science & Technology > Biotechnology and Health
CEPI's goal of making safe, effective vaccines within 100 days of identifying a new pandemic threat.
A vaccine that gives cells genetic instructions to make a harmless viral protein and trigger immunity; GEMCOVAC-19 is India's first.